186 related articles for article (PubMed ID: 3756879)
1. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas.
Shiloh Y; Korf B; Kohl NE; Sakai K; Brodeur GM; Harris P; Kanda N; Seeger RC; Alt F; Latt SA
Cancer Res; 1986 Oct; 46(10):5297-301. PubMed ID: 3756879
[TBL] [Abstract][Full Text] [Related]
2. [Oncogene amplification in human neuroblastomas].
Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
[TBL] [Abstract][Full Text] [Related]
3. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.
Tonin PN; Yeger H; Stallings RL; Srinivasan PR; Lewis WH
Oncogene; 1989 Sep; 4(9):1117-21. PubMed ID: 2780050
[TBL] [Abstract][Full Text] [Related]
4. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.
Hiemstra JL; Schneider SS; Brodeur GM
Prog Clin Biol Res; 1994; 385():51-7. PubMed ID: 7972237
[TBL] [Abstract][Full Text] [Related]
5. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.
Corvi R; Savelyeva L; Schwab M
Cancer Res; 1995 Aug; 55(16):3471-4. PubMed ID: 7627947
[TBL] [Abstract][Full Text] [Related]
6. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
7. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA.
Amler LC; Schwab M
Oncogene; 1992 Apr; 7(4):807-9. PubMed ID: 1565478
[TBL] [Abstract][Full Text] [Related]
8. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas.
Reiter JL; Brodeur GM
Genomics; 1996 Feb; 32(1):97-103. PubMed ID: 8786126
[TBL] [Abstract][Full Text] [Related]
9. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
10. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract][Full Text] [Related]
11. Analysis of a novel locus frequently co-amplified with N-myc in human neuroblastoma.
Montgomery KT; Melera PW
Prog Clin Biol Res; 1988; 271():71-88. PubMed ID: 3406025
[No Abstract] [Full Text] [Related]
12. Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas.
Schneider SS; Zehnbauer BA; Vogelstein B; Brodeur GM
Prog Clin Biol Res; 1991; 366():71-6. PubMed ID: 2068181
[TBL] [Abstract][Full Text] [Related]
13. Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines.
Shiloh Y; Shipley J; Brodeur GM; Bruns G; Korf B; Donlon T; Schreck RR; Seeger R; Sakai K; Latt SA
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3761-5. PubMed ID: 3858848
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.
Oberthuer A; Skowron M; Spitz R; Kahlert Y; Westermann F; Mehler K; Berthold F; Fischer M
Gene; 2005 Dec; 363():41-50. PubMed ID: 16216448
[TBL] [Abstract][Full Text] [Related]
16. Amplification of IMR-32 clones 8, G21, and N-myc in human neuroblastoma xenografts.
Kanda N; Tsuchida Y; Hata J; Kohl NE; Alt FW; Latt SA; Utakoji T
Cancer Res; 1987 Jun; 47(12):3291-5. PubMed ID: 3034408
[TBL] [Abstract][Full Text] [Related]
17. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
18. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
[TBL] [Abstract][Full Text] [Related]
19. Increased N-myc expression following progressive growth of human neuroblastoma.
Rosen N; Reynolds CP; Thiele CJ; Biedler JL; Israel MA
Cancer Res; 1986 Aug; 46(8):4139-42. PubMed ID: 3731081
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
